ArticleDiscover oncology2025
Research trends between acquired immune deficiency syndrome and hematological malignancies: a bibliometric analysis.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Clinical characterization and targeted genetic mutation profiling of autoimmune disease-associated B-cell lymphoma.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveThis study examines the well-documented association between HIV/AIDS and hematological malignancies, where HIV infection increases the risk of developing these conditions, using bibliometric analysis to explore research trends and global patterns.
methodsA bibliometric analysis was performed using the Web of Science Core Collection database, focusing on English-language articles related to "HIV/AIDS" and "hematological malignancies" published from 1979 to August 2024, employing VOSviewer, CiteSpace, and R package "Bibliometrix" for data analysis and visualization.
resultsA total of 1336 relevant articles were identified, with the United States as the leading contributor, followed by China. Prominent research institutions included the Université Paris Cité, publique hopitaux paris (APHP) and Harvard University. Blood is the most influential journal in this field, while authors Elie Azoulay and Hans-Peter Kiem were noted as influential figures. Keyword analysis highlighted bone marrow transplantation, lymphoma, and epidemiology as key research areas.
conclusionThis study analyzed the evolving research landscape, hotspots, and trends in HIV/AIDS and hematological malignancies. Our findings reveal a critical shift from managing acute infections to focusing on long-term clinical outcomes, highlighting the paramount importance of continued emphasis on precise diagnostics, personalized treatment strategies, and optimized interventions like bone marrow transplantation to improve patient prognosis and survival.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.